Evidence map›Paper›PMID 31409675›Full record

ArticlemBio2019

A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators.

Loïc Martinet, Aymeric Naômé, Benoit Deflandre, Marta Maciejewska, Déborah Tellatin, Elodie Tenconi, Nicolas Smargiasso, Edwin de Pauw, Gilles P van Wezel, Sébastien Rigali

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Assessing the effect of temperature onMicrobiology (Reading, England) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Analysis of the Setomimycin Biosynthetic Gene Cluster fromInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Volatile Organic Compounds ofMicroorganisms · 2023
    Article
  16. Biosynthetic Potential ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Loïc MartinetInBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, Liège, Belgium.
Aymeric NaôméInBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, Liège, Belgium.
Benoit DeflandreInBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, Liège, Belgium.
Marta MaciejewskaInBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, Liège, Belgium.
Déborah TellatinInBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, Liège, Belgium.
Elodie TenconiInBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, Liège, Belgium.
Nicolas SmargiassoMolSys Research Unit, Mass Spectrometry Laboratory, University of Liège, Liège, Belgium.
Edwin de PauwMolSys Research Unit, Mass Spectrometry Laboratory, University of Liège, Liège, Belgium.
Gilles P van WezelMolecular Biotechnology, Institute of Biology, Leiden University, Leiden, The Netherlands.ORCID 0000-0003-0341-1561
Sébastien RigaliInBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, Liège, Belgium srigali@uliege.be.ORCID 0000-0003-4022-7325
University of Liège · BELeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biosynthetic gene clusters (BGCs) are organized groups of genes involved in the production of specialized metabolites. Typically, one BGC is responsible for the production of one or several similar compounds with bioactivities that usually only vary in terms of strength and/or specificity. Here we show that the previously described ferroverdins and bagremycins, which are families of metabolites with different bioactivities, are produced from the same BGC, whereby the fate of the biosynthetic pathway depends on iron availability. Under conditions of iron depletion, the monomeric bagremycins are formed, representing amino-aromatic antibiotics resulting from the condensation of 3-amino-4-hydroxybenzoic acid with

Indexed as

Multigene FamilyAminobenzoatesAnti-Bacterial AgentsBacterial ProteinsBiosynthetic PathwaysFerrous CompoundsGenome, BacterialIronIron Chelating AgentsMolecular StructureNitroso CompoundsPhylogenyStreptomycesAminobenzoatesAnti-Bacterial AgentsBacterial ProteinsFerrous CompoundsferroverdinIronIron Chelating AgentsNitroso Compoundsgenome analysisiron regulationnatural antimicrobial productssecondary metabolismStreptomyces

Identifiers

PMID31409675
PMCPMC6692506
OpenAlexW2966953845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.